AbbVie Submits New Drug Application to U.S. FDA for its Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Hepatitis C

AbbVie Submits New Drug Application to U.S. FDA for its Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Hepatitis C

Submitted by admin on April 22, 2014 - 9:47am
Source: 
Yahoo
News Tags: 
hepatitis C
FDA
Enanta Pharmaceuticals
ABT-450
AbbVie
Headline: 
AbbVie Submits New Drug Application to U.S. FDA for its Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Hepatitis C

Do Not Allow Advertisers to Use My Personal information